Israel Englander’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.2M | Buy |
365,972
+155,594
| +74% | +$4.85M | ﹤0.01% | 2093 |
|
|
2026
Q1 | $5.24M | Sell |
210,378
-207,818
| -50% | -$3.76M | ﹤0.01% | 2885 |
|
|
2025
Q4 | $4.84M | Sell |
418,196
-34,239
| -8% | -$325K | ﹤0.01% | 3053 |
|
|
2025
Q3 | $3.93M | Sell |
452,435
-20,789
| -4% | -$177K | ﹤0.01% | 3383 |
|
|
2025
Q2 | $3.38M | Buy |
473,224
+402,908
| +573% | +$3.29M | ﹤0.01% | 3383 |
|
|
2025
Q1 | $457K | Buy |
70,316
+29,754
| +73% | +$469K | ﹤0.01% | 4870 |
|
|
2024
Q4 | $746K | Sell |
40,562
-162,613
| -80% | -$4.96M | ﹤0.01% | 4430 |
|
|
2024
Q3 | $7.03M | Sell |
203,175
-233,014
| -53% | -$9.13M | ﹤0.01% | 2528 |
|
|
2024
Q2 | $12.8M | Sell |
436,189
-37,407
| -8% | -$1.48M | 0.01% | 1873 |
|
|
2024
Q1 | $26.8M | Buy |
473,596
+320,009
| +208% | +$14.1M | 0.01% | 1295 |
|
|
2023
Q4 | $6.59M | Buy |
153,587
+29,662
| +24% | +$941K | ﹤0.01% | 2551 |
|
|
2023
Q3 | $4.3M | Sell |
123,925
-26,434
| -18% | -$1.15M | ﹤0.01% | 2833 |
|
|
2023
Q2 | $6.99M | Buy |
150,359
+61,197
| +69% | +$3.05M | ﹤0.01% | 2356 |
|
|
2023
Q1 | $4.12M | Sell |
89,162
-47,740
| -35% | -$3.03M | ﹤0.01% | 2778 |
|
|
2022
Q4 | $11.1M | Sell |
136,902
-116,805
| -46% | -$8.12M | 0.01% | 2026 |
|
|
2022
Q3 | $14.1M | Buy |
253,707
+23,028
| +10% | +$1.36M | 0.01% | 1731 |
|
|
2022
Q2 | $12M | Buy |
230,679
+196,466
| +574% | +$11M | 0.01% | 1811 |
|
|
2022
Q1 | $2.81M | Buy |
34,213
+19,649
| +135% | +$1.87M | ﹤0.01% | 3558 |
|
|
2021
Q4 | $2.17M | Sell |
14,564
-6,894
| -32% | -$1.24M | ﹤0.01% | 3702 |
|
|
2021
Q3 | $4.05M | Sell |
21,458
-26,354
| -55% | -$5.01M | ﹤0.01% | 3119 |
|
|
2021
Q2 | $8.89M | Sell |
47,812
-7,868
| -14% | -$1.54M | 0.01% | 2060 |
|
|
2021
Q1 | $12.7M | Buy |
55,680
+28,732
| +107% | +$6.82M | 0.01% | 1530 |
|
|
2020
Q4 | $5.85M | Sell |
26,948
-4,973
| -16% | -$823K | ﹤0.01% | 2286 |
|
|
2020
Q3 | $3.21K | Buy |
31,921
+13,506
| +73% | +$1.28M | ﹤0.01% | 2215 |
|
|
2020
Q2 | $1.43M | Buy |
18,415
+15,767
| +595% | +$1.51M | ﹤0.01% | 2769 |
|
|
2020
Q1 | $270K | Sell |
2,648
-682
| -20% | -$71.7K | ﹤0.01% | 3240 |
|
|
2019
Q4 | $366K | Buy |
3,330
+726
| +28% | +$74.8K | ﹤0.01% | 3558 |
|
|
2019
Q3 | $236K | Buy |
2,604
+743
| +40% | +$75K | ﹤0.01% | 3703 |
|
|
2019
Q2 | $212K | Sell |
1,861
-1,905
| -51% | -$210K | ﹤0.01% | 3730 |
|
|
2019
Q1 | $429K | Buy |
+3,766
| New | +$392K | ﹤0.01% | 3367 |
|
|
2018
Q4 | – | Sell |
-7,666
| Closed | -$1.15M | – | 4154 |
|
|
2018
Q3 | $1.15M | Buy |
+7,666
| New | +$1.16M | ﹤0.01% | 2796 |
|
Other funds holding STRO
PA
BI
AAA
SB
KCM
O
EAM
Israel Englander's STRO Position: Q2 2026 in Review
Israel Englander increased its Sutro Biopharma (STRO) stake by 74% in Q2 2026, buying an estimated $4.85M and bringing the position to 365,972 shares worth $12.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2093.
Israel Englander first reported a position in STRO in Q3 2018 and has held it in 31 quarters since. The position peaked at $26.8M in Q1 2024. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2026.
- Israel Englander held 365,972 shares of Sutro Biopharma worth $12.2M as of Q2 2026.
- Israel Englander bought 155,594 Sutro Biopharma shares in Q2 2026, an estimated $4.85M.
- Sutro Biopharma made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2093 holding.
- Israel Englander first reported a position in Sutro Biopharma in Q3 2018 and has held it in 31 quarters since.
- Israel Englander's Sutro Biopharma position peaked at $26.8M in Q1 2024.
- 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.